UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 53

Sortiert nach

Prevalence of Vitamin D Inadequacy among Postmenopausal North American Women Receiving Osteoporosis Therapy

The journal of clinical endocrinology and metabolism, 2005-06, Vol.90 (6), p.3215-3224

2005

Volltextzugriff (PDF)

In Vivo Determination of Bone Structure in Postmenopausal Women: A Comparison of HR‐pQCT and High‐Field MR Imaging

Journal of bone and mineral research, 2008-04, Vol.23 (4), p.463-474

2008

Volltextzugriff (PDF)

Change in Bone Density and Reduction in Fracture Risk: A Meta‐Regression of Published Trials

Journal of bone and mineral research, 2019-04, Vol.34 (4), p.632-642

2019

Volltextzugriff (PDF)

Treatment‐Related Changes in Bone Turnover and Fracture Risk Reduction in Clinical Trials of Antiresorptive Drugs: Proportion of Treatment Effect Explained

Journal of bone and mineral research, 2021-02, Vol.36 (2), p.236-243

2021

Volltextzugriff (PDF)

Bone Density, Turnover, and Estimated Strength in Postmenopausal Women Treated With Odanacatib: A Randomized Trial

The journal of clinical endocrinology and metabolism, 2013-02, Vol.98 (2), p.571-580

2013

Volltextzugriff (PDF)

Treatment‐Related Changes in Bone Turnover and Fracture Risk Reduction in Clinical Trials of Anti‐Resorptive Drugs: A Meta‐Regression

Journal of bone and mineral research, 2018-04, Vol.33 (4), p.634-642

2018

Volltextzugriff (PDF)

A longitudinal HR‐pQCT study of alendronate treatment in postmenopausal women with low bone density: Relations among density, cortical and trabecular microarchitecture, biomechanics, and bone turnover

Journal of bone and mineral research, 2010-12, Vol.25 (12), p.2558-2571

2010

Volltextzugriff (PDF)

The osteoclast, bone remodelling and treatment of metabolic bone disease

European journal of clinical investigation, 2012-12, Vol.42 (12), p.1332-1341

2012

Volltextzugriff (PDF)

Effects of Odanacatib on the Radius and Tibia of Postmenopausal Women: Improvements in Bone Geometry, Microarchitecture, and Estimated Bone Strength

Journal of bone and mineral research, 2014-08, Vol.29 (8), p.1786-1794

2014

Volltextzugriff (PDF)

Reply to: Change in Bone Density and Reduction in Fracture Risk: A Meta‐Regression of Published Trials

Journal of bone and mineral research, 2019-10, Vol.34 (10), p.1977-1978

2019

Volltextzugriff (PDF)

Treatment With Once-Weekly Alendronate 70 mg Compared With Once-Weekly Risedronate 35 mg in Women With Postmenopausal Osteoporosis: A Randomized Double-Blind Study

Journal of bone and mineral research, 2005-01, Vol.20 (1), p.141-151

2005

Volltextzugriff (PDF)

Response to therapy with once-weekly alendronate 70 mg compared to once-weekly risedronate 35 mg in the treatment of postmenopausal osteoporosis

Current medical research and opinion, 2004-12, Vol.20 (12), p.2031-2041

2004

Volltextzugriff (PDF)

Comparison of Weekly Treatment of Postmenopausal Osteoporosis with Alendronate Versus Risedronate Over Two Years

The journal of clinical endocrinology and metabolism, 2006-07, Vol.91 (7), p.2631-2637

2006

Volltextzugriff (PDF)

Once-weekly alendronate 70 mg and raloxifene 60 mg daily in the treatment of postmenopausal osteoporosis

Menopause (New York, N.Y.), 2004-07, Vol.11 (4), p.405-415

2004

Volltextzugriff (PDF)

Longitudinal evaluation of the effects of alendronate on MRI bone microarchitecture in postmenopausal osteopenic women

Bone (New York, N.Y.), 2011-03, Vol.48 (3), p.611-621

2011

Volltextzugriff (PDF)

Prediction of Changes in Bone Mineral Density in Postmenopausal Women Treated with Once-Weekly Bisphosphonates

The journal of clinical endocrinology and metabolism, 2009-04, Vol.94 (4), p.1097-1103

2009

Volltextzugriff (PDF)

Tolerability of Once-Weekly Alendronate in Patients With Osteoporosis: A Randomized, Double-Blind, Placebo-Controlled Study

Mayo Clinic proceedings, 2002-10, Vol.77 (10), p.1044-1052

2002

Volltextzugriff (PDF)

Response to oral bisphosphonates in subgroups of younger and older postmenopausal women

Journal of women's health (Larchmont, N.Y. 2002), 2010-03, Vol.19 (3), p.491

2010

Volltextzugriff (PDF)

Authors’ Response: 25-OH-Vitamin D Assays

The journal of clinical endocrinology and metabolism, 2005-11, Vol.90 (11), p.6338-6338

2005

Volltextzugriff (PDF)

Comparison of Weekly Treatment of Postmenopausal Osteoporosis with Alendronate Versus Risedronate Over Two Years

Obstetrical & gynecological survey, 2007-01, Vol.62 (1), p.35-36

2007

Volltextzugriff (PDF)

Parathyroid hormone-related protein a peptide of diverse physiologic functions

Trends in Endocrinology & Metabolism, 1993-08, Vol.4 (6), p.181-187

1993

Volltextzugriff (PDF)

Prevalence of Vitamin D Inadequacy Among Postmenopausal North American Women Receiving Osteoporosis Therapy

Obstetrical & gynecological survey, 2005-10, Vol.60 (10), p.658-659

2005

Volltextzugriff (PDF)

Metastatic cervical carcinoma with ectopic calcitonin production presenting as a thyroid mass

Endocrine practice, 2002-01, Vol.8 (1), p.50-53

2002

Volltextzugriff (PDF)

A randomized, placebo-controlled, 6-month study of once-weekly alendronate oral solution for postmenopausal osteoporosis

The American journal of geriatric pharmacotherapy, 2005-09, Vol.3 (3), p.127-136

2005

Volltextzugriff (PDF)

Parathyroid carcinoma arising from parathyroid hyperplasia: Autoinfarction following intravenous treatment with pamidronate

The American journal of medicine, 1994-10, Vol.97 (4), p.399-400

1994

Volltextzugriff (PDF)

1 – 25 von 53

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(53)
Mit Volltextzugriff
(49)

Publikationsform

Artikel
(53)

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(39)
Science & Technology
(38)
Life Sciences & Biomedicine
(36)
Female
(31)
Endocrinology & Metabolism
(18)
Biological And Medical Sciences
(15)
Double-Blind Method
(14)
Middle Aged
(13)
Treatment Outcome
(13)
Adult
(12)
Aged
(11)
Fundamental And Applied Biological Sciences. Psychology
(11)
Medical Sciences
(10)
Osteoporosis, Postmenopausal - Drug Therapy
(10)
Bone Density
(8)
Osteoporosis
(8)
Risk Factors
(8)
Alendronate
(7)
Adolescent
(6)
Alendronate - Administration & Dosage
(6)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Prevalence of Vitamin D Inadequacy among Postmenopausal North American Women Receiving Osteoporosis Therapy

In Vivo Determination of Bone Structure in Postmenopausal Women: A Comparison of HR‐pQCT and High‐Field MR Imaging

Change in Bone Density and Reduction in Fracture Risk: A Meta‐Regression of Published Trials

Treatment‐Related Changes in Bone Turnover and Fracture Risk Reduction in Clinical Trials of Antiresorptive Drugs: Proportion of Treatment Effect Explained

Bone Density, Turnover, and Estimated Strength in Postmenopausal Women Treated With Odanacatib: A Randomized Trial

Treatment‐Related Changes in Bone Turnover and Fracture Risk Reduction in Clinical Trials of Anti‐Resorptive Drugs: A Meta‐Regression

A longitudinal HR‐pQCT study of alendronate treatment in postmenopausal women with low bone density: Relations among density, cortical and trabecular microarchitecture, biomechanics, and bone turnover

The osteoclast, bone remodelling and treatment of metabolic bone disease

Effects of Odanacatib on the Radius and Tibia of Postmenopausal Women: Improvements in Bone Geometry, Microarchitecture, and Estimated Bone Strength

Reply to: Change in Bone Density and Reduction in Fracture Risk: A Meta‐Regression of Published Trials

Treatment With Once-Weekly Alendronate 70 mg Compared With Once-Weekly Risedronate 35 mg in Women With Postmenopausal Osteoporosis: A Randomized Double-Blind Study

Response to therapy with once-weekly alendronate 70 mg compared to once-weekly risedronate 35 mg in the treatment of postmenopausal osteoporosis

Comparison of Weekly Treatment of Postmenopausal Osteoporosis with Alendronate Versus Risedronate Over Two Years

Once-weekly alendronate 70 mg and raloxifene 60 mg daily in the treatment of postmenopausal osteoporosis

Longitudinal evaluation of the effects of alendronate on MRI bone microarchitecture in postmenopausal osteopenic women

Prediction of Changes in Bone Mineral Density in Postmenopausal Women Treated with Once-Weekly Bisphosphonates

Tolerability of Once-Weekly Alendronate in Patients With Osteoporosis: A Randomized, Double-Blind, Placebo-Controlled Study

Response to oral bisphosphonates in subgroups of younger and older postmenopausal women

Authors’ Response: 25-OH-Vitamin D Assays

Comparison of Weekly Treatment of Postmenopausal Osteoporosis with Alendronate Versus Risedronate Over Two Years

Parathyroid hormone-related protein a peptide of diverse physiologic functions

Prevalence of Vitamin D Inadequacy Among Postmenopausal North American Women Receiving Osteoporosis Therapy

Metastatic cervical carcinoma with ectopic calcitonin production presenting as a thyroid mass

A randomized, placebo-controlled, 6-month study of once-weekly alendronate oral solution for postmenopausal osteoporosis

Parathyroid carcinoma arising from parathyroid hyperplasia: Autoinfarction following intravenous treatment with pamidronate

Suchergebnisse filtern